Dysregulation of the fibroblast growth factor system in major depression
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
In this report we describe findings that imply dysregulation of several fibroblast growth factor (FGF) system transcripts in frontal cortical regions of brains from human subjects with major depressive disorder (MDD). This altered gene expression was discovered by microarray analysis of frontal cortical tissue from MDD, bipolar, and nonpsychiatric control subjects and was verified by quantitative real-time PCR analysis and, importantly, in a separate cohort of MDD subjects. Furthermore, we show, through a separate analysis of specific serotonin reuptake inhibitor (SSRI)-treated and non-SSRI-treated MDD subjects that the observed changes in expression of FGF transcripts are not secondary to drug treatment. Rather, changes in specific FGF transcripts are attenuated by SSRIs and may thus be partially responsible for the mechanism of action of these drugs. We also make available the gene-expression profile of all of the other growth factors and growth factor receptors detected in these postmortem samples.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Post-mortem brain analysis in humans revealed a lower expression of FGF1 and FGF2 in the dorsolateral PFC and the ACC of patients with MDD (Evans et al. 2004).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Evans et al. 2004
Citations
Cites
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
More powerful procedures for multiple significance testing
Hochberg, Y., & Benjamini, Y. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090710 · Cited by 2,715
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma
Gilbertson, M. W., Shenton, M. E., Ciszewski, A., Kasai, K., Lasko, N. B., Orr, S. P., & Pitman, R. K. (2002) · Nature Neuroscience · doi:10.1038/nn958 · Cited by 1,635
Shimizu, E., Hashimoto, K., Okamura, N., Koike, K., Komatsu, N., Kumakiri, C., Nakazato, M., Watanabe, H., Shinoda, N., Okada, S.-I., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00181-1 · Cited by 1,151
Lee, J., Duan, W., & Mattson, M. P. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01085.x · Cited by 975
Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia
Weickert, C. S., Hyde, T. M., Lipska, B. K., Herman, M. M., Weinberger, D. R., & Kleinman, J. E. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001308 · Cited by 532
Tomita, H., Vawter, M. P., Walsh, D. M., Evans, S. J., Choudary, P. V., Li, J., Overman, K. M., Atz, M. E., Myers, R. M., Jones, E. G., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.10.013 · Cited by 331
Self-citationThe neuropathology of primary mood disorder
Harrison, P. J. (2002) · Brain · doi:10.1093/brain/awf149 · Cited by 322
López-Figueroa, A. L., Norton, C. S., López-Figueroa, M. O., Armellini-Dodel, D., Burke, S., Akil, H., López, J. F., & Watson, S. J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.09.017 · Cited by 296
Self-citation
Research works printed but not linked: 4
- Watson S. J. Patel P. Burke S. Herman J. Shaffer M. & Kwak S. (1988) in Short Course 1 Syllabus ed. Sunderman A. (Soc. Neurosci. Washington DC) pp. 4-29.
- Neal, C. R., Jr., Akil, H. & Watson, S. J., Jr. (2001) J. Chem. Neuroanat. 22, 219-249.11719021
- Parikh, V., Evans, D. R., Khan, M. M. & Mahadik, S. P. (2003) Schizophr. Res. 60, 117-123.12591576
- Dono, R. (2003) Am. J. Physiol. 284, R867-R881.
Cited by
Items 201–300 of 466
Bernard, R., Kerman, I. A., Meng, F., Evans, S. J., Amrein, I., Jones, E. G., Bunney, W. E., Akil, H., Watson, S. J., & Thompson, R. C. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.11.012 · Cited by 30
“Subjects Acquisition of postmortem human brain samples, tissue processing, and procedures for microarray experiments have been previously described (Evans et al., 2003; Evans et al., 2004; Li et al., 2004; Tomita et al., 2004; Choudary et al., 2005).”
Self-citationRahbek, U. L., Tritsaris, K., & Dissing, S. (2005) · Research at the University of Copenhagen (University of Copenhagen) · Cited by 30
Nguyen, H. D., & Kim, M. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.09.108 · Cited by 28
Fiori, L. M., & Turecki, G. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.11.004 · Cited by 24
“It is thus of interest that several microarray studies have found altered expression of both BDNF and NTRK2 in the brains of depressed subjects (Evans et al., 2004; Aston et al., 2005; Kim and Webster, 2010b; Bernard et al., in press).”
BackgroundInfluentialConnective Tissue Growth Factor Is a Novel Prodepressant
Turner, C. A., Sharma, V., Hagenauer, M. H., Chaudhury, S., O’Connor, A. M., Hebda‐Bauer, E. K., Thompson, R. C., Myers, R., Bunney, W. E., Barchas, J. D., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.04.013 · Cited by 27
“The tissue samples were obtained from the Brain Donor Program at the University of California, Irvine, with the consent of the next of kin (4,19).”
Self-citationGenetic mouse models for behavioral analysis through transgenic RNAi technology
Delic, S., Streif, S., Deussing, J. M., Weber, P., Ueffing, M., Hölter, S. M., Wurst, W., & Kühn, R. (2008) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2008.00412.x · Cited by 27
“In MDD patients, reduced expression of the Fgfr2 and Fgfr3 genes have been described in certain brain areas (Evans et al., 2004).”
BackgroundIs Cerebrospinal Fluid Fibroblast Growth Factor 19 (FGF19) a mood regulator?
Liu, Y., Yu, D., Wang, X., Tan, X., Luo, X., Fan, H., Kang, Y., Xiao, J., Li, X., & Wang, F. (2017) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000187 · Cited by 26
“Previous studies have shown that dysregulation of the FGF system in major depression involves FGF receptors and several FGF ligands [8].”
BackgroundKajitani, N., Hisaoka‐Nakashima, K., Okada‐Tsuchioka, M., Hosoi, M., Yokoe, T., Morioka, N., Nakata, Y., & Takebayashi, M. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13247 · Cited by 26
Moon, E. A., Rollins, B. L., Mesén, A., Sequeira, A., Myers, R., Akil, H., Watson, S. J., Barchas, J. D., Jones, E. G., Schatzberg, A. F., et al. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.06.024 · Cited by 26
“Since NRG1 has strong pleiotropic effects related to growth factor signaling in the brain, the findings of decreased NRG1 expression in prefrontal cortex could lend support to the overall growth factor hypothesis of depression (Evans et al., 2004).”
ResultSelf-citationGupta, S., Redmond, T. M., Meng, F., Tidball, A. M., Akil, H., Watson, S. J., Parent, J. M., & Uhler, M. D. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14255 · Cited by 27
Self-citationScarr, E., Udawela, M., & Dean, B. (2019) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867419857808 · Cited by 26
“…like others, we show that differential changes in gene expression are present in different cortical regions from individuals with MD (Choudary et al., 2005; Evans et al., 2004; Klempan et al., 2009; Sequeira et al., 2007; Sequeira et al., 2009) and BD (Choudary et al., 2005; Evans et al., 2004).”
BackgroundResultInfluentialLiu, Y., Wang, M., Tan, X., Wang, X., Yang, X., Xiao, J., Li, X., & Wang, F. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.01.075 · Cited by 26
Kato, M., Serretti, A., Nonen, S., Takekita, Y., Wakeno, M., Azuma, J., & Kinoshita, T. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.6 · Cited by 25
Fadda, P., Bedogni, F., Fresu, A., Collu, M., Racagni, G., & Riva, M. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.003 · Cited by 24
Aonurm‐Helm, A. (2010) · DSpace repository (University of Tartu) · Cited by 27
Biomarkers and detection methods of bipolar disorder
Hu, X., Yu, C., Dong, T., Yang, Z., Fang, Y., & Jiang, Z. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114842 · Cited by 23
Güldiken, G., Karayağmurlu, A., Küçükgergin, C., & Coşkun, M. (2023) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-023-06089-1 · Cited by 24
“Recent postmortem studies reporting dysregulated expressions of FGF transcripts, including FGF-2, in major depression have provided further evidence that neurotrophic molecules may be involved in the etiology and treatment of mood disorders (Evans et al., 2004 ; Riva et al., 2005).”
Mocchetti, I., Bachis, A., Campbell, L. A., & Avdoshina, V. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9488-y · Cited by 23
“Indeed, alterations in FGF2 expression are seen in cortical brain regions in individuals with major depression compared to control subjects (Evans et al. 2004).”
Graham, B. M., & Richardson, R. (2010) · Behavioral Neuroscience · doi:10.1037/a0019582 · Cited by 23
Is Brain Banking of Psychiatric Cases Valuable for Neurobiological Research?
Schmitt, A., Parlapani, E., Bauer, M., Heinsen, H., & Falkai, P. (2008) · Clinics · doi:10.1590/s1807-59322008000200015 · Cited by 24
Neurogenesis within the adult hippocampus under physiological conditions and in depression.
Dokter, M., & Halbach, O. V. B. U. (2012) · PubMed Central · doi:10.3969/j.issn.1673-5374.2012.07.013 · Cited by 23
“By comparing depressed subjects, treated with antidepressants, with untreated depressed subjects, it was demonstrated that depression-induced changes in fibroblast growth factor (FGF) transcripts, including FGF-2, were attenuated by antidepressant treatment [92] .”
BackgroundOlanzapine/Fluoxetine: A Review of its Use in the Treatment of Acute Bipolar Depression
Deeks, E. D., & Keating, G. M. (2008) · Drugs · doi:10.2165/00003495-200868080-00008 · Cited by 23
Tang, C., Wang, Y., & Hong, H. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.116482 · Cited by 22
A review of new insights into existing major depressive disorder biomarkers
Rimti, F. H., Shahbaz, R., Bhatt, K., & Xiang, A. J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18909 · Cited by 23
Agonist-induced formation of FGFR1 homodimers and signaling differ among members of the FGF family
Romero‐Fernandez, W., Borroto‐Escuela, D. O., Tarakanov, A. O., Mudò, G., Narváez, M., Pérez‐Alea, M., Agnati, L. F., Ciruela, F., Belluardo, N., & Fuxé, K. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.05.085 · Cited by 22
“Anomalous FGF signaling is associated with several human diseases, for instance uncontrolled FGF signaling has been linked to the etiology of neurodegenerative disorders, such as major depressive disorder and Parkinson’s disease [6].”
BackgroundWang, T., Zeng, Z., Hu, Z., Zheng, L., Li, T., Li, Y., Liu, J., Li, J., Feng, G., He, L., et al. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.650203 · Cited by 22
Self-citationGraham, B. M., Zagic, D., & Richardson, R. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.03.020 · Cited by 22
Quantitative assessment of fibroblast growth factor receptor 1 expression in neurons and glia
Choubey, L., Collette, J. C., & Smith, K. M. (2017) · PeerJ · doi:10.7717/peerj.3173 · Cited by 22
“FeF22 and FeF7 are presynaptic organizing molecules that promote differentiation of excitatory and inhibitory presynaptic terminals in the hippocampal cornu ammonis (CA) region 3 through combinatorial signaling of sets of FeFRs (Umemori et al., 2004, Terauchi et al., 2010, Dabrowski et al., 2015). eiven the data that…”
BackgroundInfluentialChen, B., Zhang, M., Ji, M., Gong, W., Chen, B., Zorec, R., Stenovec, M., Verkhratsky, A., & Li, B. (2021) · Neurochemical Research · doi:10.1007/s11064-020-03225-6 · Cited by 23
Zhai, X., Liu, J., Ni, A., & Ye, J. (2020) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2020.101872 · Cited by 21
Characterization of cell-cell communication in autistic brains with single-cell transcriptomes
Astorkia, M., Lachman, H. M., & Zheng, D. (2022) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-022-09441-1 · Cited by 21
“[67] linked decreased expression of FGF1, FGF2, FGFR2, and FGFR3 in cortical areas to depressive disorder, while Liu et al.”
BackgroundFGF-2 induces neuronal death through upregulation of system xc-
Liu, X., Albano, R., & Lobner, D. (2013) · Brain Research · doi:10.1016/j.brainres.2013.12.018 · Cited by 21
Sample matching by inferred agonal stress in gene expression analyses of the brain
Li, J. Z., Meng, F., Tsavaler, L., Evans, S. J., Choudary, P. V., Tomita, H., Vawter, M. P., Walsh, D., Shokoohi, V., Chung, T., et al. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-336 · Cited by 19
“Sample acquisition, RNA labeling, and microarray hybridization were carried out as described previously [6, 48 ].”
MethodSelf-citationAcross Barriers: Blood–Brain and Gut Barrier Signaling in Psychiatric Disorders
Binder, L. B., Bevilacqua, L. M., Thomassen, F. G. L., Lebel, M., Jensen, B. A. H., & Ménard, C. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70282 · Cited by 20
“FGF signaling has also been linked to antidepressant treatment response (Evans et al. 2004; Wang, Li, et al. 2018), suggested as a potential diagnostic biomarker for GAD (Graham 2017), and a prognostic IBD biomarker.”
Neurotrophic Factor-α1/Carboxypeptidase E Functions in Neuroprotection and Alleviates Depression
Xiao, L., & Loh, Y. P. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.918852 · Cited by 20
Touchant, M., & Labonté, B. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.845491 · Cited by 20
“Other studies of cortical regions reported alterations in lipid metabolism, immune response, ATP synthesis, regulation of transcription and translation, fibroblast growth factor signaling, and cell proliferation (Evans et al., 2004; Iwamoto et al., 2004; Kang et al., 2007; Tochigi et al., 2008; Klempan et al., 2009; L…”
BackgroundAdaptive changes in gene expression patterns in the somatosensory cortex after deletion of ephrinA5
Peuckert, C., Wacker, E., Rapus, J., Levitt, P. R., & Bolz, J. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.05.011 · Cited by 20
Mastronardi, C. A., Pillai, E., Pineda, D. A., Martinez, A. F., Lopera, F., Velez, J. I., Palacio, J. D., Patel, H., Easteal, S., Acosta, M. T., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.172 · Cited by 19
Genetic Variation Underpinning ADHD Risk in a Caribbean Community
Rozo, P. J. P., Acosta-López, J. E., Cervantes-Henríquez, M. L., Martínez-Banfi, M. L., Mejía-Segura, E., Sánchez-Rojas, M., Anaya-Romero, M., Acosta-Hoyos, A. J., Llinás, G. A. G., Mastronardi, C. A., et al. (2019) · Cells · doi:10.3390/cells8080907 · Cited by 19
“, prefrontal cortex and the anterior cingulate cortex) [82] that may also be relevant to ADHD.”
BackgroundBreitfeld, J., Scholl, C., Steffens, M., Brandenburg, K., Probst-Schendzielorz, K., Efimkina, O., Gurwitz, D., Ising, M., Holsboer, F., Lucae, S., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.185 · Cited by 19
Treatment Resistant Depression: A Roadmap for Effective Care
Riba, M. B., & McInnis, M. G. (2011) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615378197 · Cited by 19
Weaving the neuronal net with target‐derived fibroblast growth factors
Umemori, H. (2009) · Development Growth & Differentiation · doi:10.1111/j.1440-169x.2008.01079.x · Cited by 19
Rossi, E. L. (2005) · American Journal of Clinical Hypnosis · doi:10.1080/00029157.2005.10401514 · Cited by 19
“Researchers have already utilized DNA microarrays to characterize a variety of psychological states and conditions such as depression (Evans et al., 2004), posttraumatic stress (Segman et al.”
Collette, J. C., Choubey, L., & Smith, K. M. (2017) · PeerJ · doi:10.7717/peerj.3519 · Cited by 18
“Furthermore, FGF2 and FGFR1 signaling in the prefrontal cortex is implicated in human depression and in rodent models of depression (Elsayed et al., 2012; Bachis et al., 2008; Kang et al., 2007; Gaughran et al., 2006; Evans et al., 2004).”
BackgroundRahman, M. R., Islam, T., Al-Mamun, M. A., Zaman, T., Karim, M. R., & Moni, M. A. (2019) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2019.100207 · Cited by 18
Caffino, L., Mottarlini, F., Mingardi, J., Zita, G., Barbon, A., & Fumagalli, F. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108161 · Cited by 18
“(Evans et al. 2004; Riva et al. 2005) and whose expression has been shown to be up-regulated by antidepressant treatments in rodents (Maragnoli et al.”
BackgroundMolecular Biological Aspects of Depressive Disorders: A Modern View
Ushakova, V. M., Morozova, A. Y., Reznik, A. M., Kostyuk, G. P., & Chekhonin, V. P. (2020) · Molecular Biology · doi:10.1134/s0026893320050118 · Cited by 17
Sandberg, J. V., Hansson, C., Göteson, A., Joas, E., Jakobsson, J., Pålsson, E., & Landén, M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01648-x · Cited by 17
“Decreased expression of FGFR2 has been found in brain regions of postmortem depressed patients [55, 56] as well as that of suicide victims [57].”
BackgroundPlausible Role of Stem Cell Types for Treating and Understanding the Pathophysiology of Depression
Sachdeva, P., Ji, S., Ghosh, S., Ghosh, S., Raghunath, M., Kim, H., Bhaskar, R., Sinha, J. K., & Han, S. S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030814 · Cited by 17
“It has been reported that reduced GDNF levels abnormally regulate serotonergic neurons and reduce post and pre-synaptic serotonin receptors in patients with depression [46].”
BackgroundInactivation of fibroblast growth factor binding protein 3 causes anxiety-related behaviors
Yamanaka, Y., Kitano, A., Takao, K., Prasansuklab, A., Mushiroda, T., Yamazaki, K., Kumada, T., Shibata, M., Takaoka, Y., Awaya, T., et al. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.09.003 · Cited by 17
“Moreover, although mood disorders in humans have been ascribed to FGF dysfunction (Evans et al., 2004; Gaughran et al., 2006; Turner et al., 2006), the specific role played by various brain regions in FGF regulation and themechanisms via which these different regions contribute to anxiety disorders remain unknown.”
Yan, J., Zhang, F., Niu, L., Wang, X., Lu, X., Ma, C., Zhang, C., Song, J., & Zhang, Z. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.02.020 · Cited by 17
Impact of Lithium Treatment on FGF-23 Serum Concentrations in Depressive Patients
Fakhri, H., Ricken, R., Adli, M., Fajol, A., Walter, M., Föller, M., Lang, F. J. W., Lang, U. E., & Lange, C. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000163 · Cited by 17
“Our data are in line with an observed dysregulation of several FGF system transcripts in the frontal cortical regions of the brains of human subjects with major depressive disorder.(21) Fibroblast growth factor is a growth factor essential for the proper formation of synaptic connections in the cerebral cortex, matura…”
BackgroundResultGenomic studies of mood disorders -- the brain as a muscle?
Niculescu, A. B. (2005) · Genome biology · doi:10.1186/gb-2005-6-4-215 · Cited by 17
“study [5] of gene expression in the brains of people with major depression gives some insights into the genes involved in this disorder.”
BackgroundResultInfluentialMolecular Targets of Alcohol Action
Gorini, G., Bell, R. L., & Mayfield, R. D. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385506-0.00007-7 · Cited by 16
“Furthermore, psychiatric disorders such as major depression (137), bipolar disorder (138), schizophrenia (69, 139, 140), and autism (141) have been studied successfully as well.”
Fibroblast Growth Factor-2: An Endogenous Antidepressant and Anxiolytic Molecule?
Turner, C. A., Watson, S. J., & Akil, H. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.05.025 · Cited by 16
“Our group, he Pritzker Neuropsychiatric Disorders Research Consortium, was the rst to describe that FGF2 was down-regulated in frontal cortical areas f individuals who had suffered from MDD when compared with conrols (3).”
Self-citationBarney, T. M., Vore, A. S., & Deak, T. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.884197 · Cited by 16
Ambrogini, P., Lattanzi, D., Pagliarini, M., Palma, M. D., Sartini, S., Cuppini, R., Fuxé, K., & Borroto‐Escuela, D. O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087467 · Cited by 16
“According to the literature, depressed animals exhibit lower serotonin levels [32], which may be the cause of cellular adaptation events that would lead to lower numbers of pre- and post-synaptic heteroreceptors [33].”
BackgroundGiannotti, G., Caffino, L., Mottarlini, F., Racagni, G., & Fumagalli, F. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4315-9 · Cited by 16
Azhar, M., Zeng, G., Ahmed, A., Farooq, A. D., Choudhary, M. I., Jiang, D., & Liu, X. (2020) · Phytotherapy Research · doi:10.1002/ptr.6810 · Cited by 16
The Neuroplastins: Multifunctional Neuronal Adhesion Molecules—Involvement in Behaviour and Disease
Beesley, P. W., Kraus, M., & Parolaro, N. (2013) · Advances in neurobiology · doi:10.1007/978-1-4614-8090-7_4 · Cited by 16
Looking Forward in Geriatric Anxiety and Depression: Implications of Basic Science for the Future
Gershenfeld, H. K., Philibert, R. A., & Boehm, G. W. (2005) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200512000-00002 · Cited by 16
Paton, S. E. J., Solano, J. L., Cadoret, A., Collignon, A., Binder, L. B., Daigle, B., Bevilacqua, L. M., Richer, É., Coulombe-Rozon, F., Dion‐Albert, L., et al. (2026) · Nature Communications · doi:10.1038/s41467-025-68058-9 · Cited by 15
Hu, Q., Wang, C., Liu, F., He, J., Fen, W., Wang, W., & You, P. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.12.159 · Cited by 15
New Approaches to the Pharmacological Management of Major Depressive Disorder
Witkin, J. M., & Li, X. (2009) · Advances in pharmacology · doi:10.1016/s1054-3589(08)57009-8 · Cited by 15
Cerebrospinal fluid FGF23 levels correlate with a measure of impulsivity
Li, H., Cao, Z., Xu, J., Wang, F., Xiong, R., Xu, Z., Luo, X., Li, G., Tan, X., Liu, Z., et al. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.04.032 · Cited by 14
Fibroblast Growth Factor 2 Implicated in Childhood Anxiety and Depression Symptoms
Lebowitz, E. R., Orbach, M., Marin, C. E., Salmaso, N., Vaccarino, F. M., & Silverman, W. K. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.12.055 · Cited by 14
“These results are in line with those found in animal studies: Low hippocampal FGF2 levels in rodents are associated with high anxious- and depressive-like behavior (ErenKocak et al., 2011; Evans et al., 2004; Perez et al., 2009; Turner et al., 2011; Turner et al., 2012).”
BackgroundResultOlianas, M. C., Dedoni, S., & Onali, P. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119407 · Cited by 14
Fgf9 Y162C Mutation Alters Information Processing and Social Memory in Mice
Garrett, L., Becker, L., Rozman, J., Puk, O., Stoeger, T., Yildirim, A. Ö., Bohla, A., Eickelberg, O., Hans, W., Prehn, C. P., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0659-3 · Cited by 14
“As mentioned, there is evidence to suggest a role for FGF9 in the pathogenesis of major depressive disorder (MDD, [10, 11]).”
BackgroundAbnormalities in FGF family members and their roles in modulating depression‐related molecules
Xu, Y., Zhu, Y., Zhu, Y., Wei, H., Zhang, N., Qin, J., Zhu, X., Yu, M., & Li, Y. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14570 · Cited by 14
“In patients with MDD, high expression levels of FGF9 are found in the frontal cortex (Evans et al., 2004), locus coeruleus and hippocampus (Aurbach et al.”
BackgroundInfluentialPark, J. Y., Chae, S., Kim, C. S., Kim, Y. J., Yi, H. J., Han, E.-J., Joo, Y., Hong, S., Yun, J. W., Kim, H., et al. (2019) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2019.23.6.427 · Cited by 14
Terauchi, A., Gavin, E., Wilson, J., & Umemori, H. (2017) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2017.00017 · Cited by 15
“Alteration in the FGF and FGF receptor signaling has been found in many neuropsychiatric diseases, including depression (Evans et al., 2004), altered social behavior (Scearce-Levie et al., 2008), seizures (Terauchi et al., 2010; Williams and Umemori, 2014), and intellectual disability (Williams and…”
BackgroundAn allostatic epigenetic memory on chromatin footprints after double-hit acute stress
Caradonna, S. G., Paul, M. R., & Marrocco, J. (2022) · Neurobiology of Stress · doi:10.1016/j.ynstr.2022.100475 · Cited by 13
“The vHPC is a functionally distinct from the dorsal hippocampus (Fanselow and Dong, 2010), and also shows a discrete epigenome (Zhang et al., 2018) and distinct role in the regulation of the stress response (Maggio and Segal, 2009).”
Zhong, X.-L., Du, Y., Chen, L. T., & Cheng, Y. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.06.017 · Cited by 13
Repositioning of receptor tyrosine kinase inhibitors
Mansour, H. M., & El-Khatib, A. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18677-6.00010-5 · Cited by 13
Effects of FGF receptor peptide agonists on animal behavior under normal and pathological conditions
Rudenko, O., Tkach, V., Berezin, V., & Bock, E. (2010) · Neuroscience Research · doi:10.1016/j.neures.2010.05.002 · Cited by 13
Graham, B. M., Dong, V., & Richardson, R. (2018) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2018.09.004 · Cited by 13
“, 2012; Mallei, Shi, & Mocchetti, 2002; Maragnoli, Fumagalli, Gennarelli, Racagni, & Riva, 2004) and humans (Evans et al., 2004).”
Application of microarray outlier detection methodology to psychiatric research
Ernst, C., Bureau, A., & Turecki, G. (2008) · BMC Psychiatry · doi:10.1186/1471-244x-8-29 · Cited by 13
Siddarth, P., Abikenari, M. A., Grzenda, A. L., Cappelletti, M., Oughli, H. A., Liu, C. Y., Milillo, M. M., & Lavretsky, H. (2022) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2022.08.004 · Cited by 12
Martins‐Macedo, J., Salgado, A. J., Gomes, E. D., & Pinto, L. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.09.030 · Cited by 12
Neurotrophic Factors and Antidepressant Action: Recent Advances
O’Leary, O. F., & Ċastrén, E. (2010) · Modern trends in psychiatry · doi:10.1159/000319514 · Cited by 13
Молекулярно-биологические аспекты депрессивных состояний: современный взгляд на проблему
Ushakova, V. M., Морозова, А. Ю., Reznik, A. M., Kostyuk, G. P., & Chekhonin, V. P. (2020) · Molecular Biology · doi:10.31857/s0026898420050110 · Cited by 12
Xu, H., Jiang, B., Cao, Y., Zhang, Y., Zhan, X., Shen, X., Cheng, S., Lou, X., & Cao, L. (2015) · BioMed Research International · doi:10.1155/2015/135782 · Cited by 12
Emerging roles of system antiporter and its inhibition in CNS disorders
Patel, D., Kharkar, P. S., & Nandave, M. (2015) · Molecular Membrane Biology · doi:10.3109/09687688.2015.1096972 · Cited by 12
“Since GSH diminution has been associated in depres- sion along with disturbance of the FGF-2 system, it is likely that the pathological effects of FGF-2 disruption are likely to be associated to reduced system x c activity but still we require studies proving the role of system x c .”
BackgroundInfluentialCervantes-Henríquez, M. L., Acosta-López, J. E., Ahmad, M., Sánchez-Rojas, M., Jiménez‐Figueroa, G., Pineda‐Alhucema, W., Martínez-Banfi, M. L., Noguera-Machacón, L. M., Mejía-Segura, E., Hoz, M. D. L., et al. (2021) · Brain Sciences · doi:10.3390/brainsci11070854 · Cited by 11
Neurobiology of Mood Disorders
Manchia, M., & Schatzberg, A. F. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_83 · Cited by 11
Toward Early, Personalized, Rational Polypharmacy In Psychiatry: A Tri-Dimensional Approach
Niculescu, A. B., & Hulvershorn, L. A. (2010) · Psychopharm Review · doi:10.1097/01.idt.0000366925.86837.fe · Cited by 10
Jiménez, K. M., Pereira‐Morales, A. J., Adán, A., López‐León, S., & Forero, D. A. (2018) · Molecular Brain · doi:10.1186/s13041-018-0397-0 · Cited by 10
“for MDD, considering previous studies that have shown an association between growth factor levels and hippocampal volume, taking into account that hippocampal volume has been negatively correlated with susceptibility to stress-induced disease [9], such as anxiety disorders, including posttraumatic stress disorder.”
MethodResultJones, R. W., Morris, K., & Nutt, D. J. (2007) · Elsevier eBooks · doi:10.1016/b978-012370624-9/50011-6 · Cited by 10
Molecular programs underlying differences in the expression of mood disorders in males and females
Mena, F., & Benoit, L. (2019) · Brain Research · doi:10.1016/j.brainres.2019.05.016 · Cited by 9
Dysregulation of FGFR1 signaling in the hippocampus facilitates depressive disorder
Shin, J., Oh, H., Park, J. H., Bae, H., Yang, C.-M., Lee, M., Kim, S., & Heo, W. D. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01519-9 · Cited by 9
Fibroblast Growth Factor 9 as a Potential Biomarker for Schizophrenia
Li, X., Yu, Y., Hu, Y., Wu, H., Li, X.-S., Chen, G.-Y., & Cheng, Y. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.788677 · Cited by 9
“expression was significantly up-regulated in frontal cortex (19) and locus coeruleus (24) of patients with major depression.”
BackgroundThümmler, K., Wrzos, C., Franz, J., McElroy, D., Cole, J. J., Hayden, L., Arseni, D., Schwarz, F., Junker, A., Edgar, J. M., et al. (2023) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12935 · Cited by 10
Jaber, M. H., Kahwaji, H., Nasr, S., Baz, R., Kim, Y., & Fakhoury, M. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-981-97-4402-2_18 · Cited by 9
GPCR oligomerization as a target for antidepressants: Focus on GPR39
Młyniec, K., Siodłak, D., Doboszewska, U., & Nowak, G. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107842 · Cited by 9
Rodriguez, K. M., Stevenson, E. L., Stewart, C. E., Linscott, M. L., & Chung, W. C. J. (2015) · Behavioral and Brain Functions · doi:10.1186/s12993-015-0081-9 · Cited by 9
“For instance, FGF1, FGF2, FGF receptor (FGFR) 2 and FGFR3 were significantly down-regulated in the frontal cortex of MDD patients, which strongly suggests that FGF signaling must be disrupted in mood disorders [2, 3].”
BackgroundXia, J., Xue, X., Liu, W., Qi, Z., & Liu, W. (2021) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000953 · Cited by 9
Amaratunga, D., Göhlmann, H. W. H., & Peeters, P. J. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00078-x · Cited by 9
AMEND: active module identification using experimental data and network diffusion
Boyd, S. S., Slawson, C. M., & Thompson, J. A. (2023) · BMC Bioinformatics · doi:10.1186/s12859-023-05376-z · Cited by 8
“FGFR signaling is involved in the regulation of various neuronal processes, including proliferation and survival [49], and has been shown to be related to depression [49–51].”
BackgroundZimering, M. B., Behnke, J. A., Thakker-Varia, S., & Alder, J. (2015) · Journal of Endocrinology and Diabetes · doi:10.15226/2374-6890/2/2/00119 · Cited by 8
“Major depressive disorder was associated with markedly reduced endogenous FGF expression in mood-regulatory, frontocortical brain regions [22].”
BackgroundTerauchi, A., Durlacher, E., Pitino, J. C., & Umemori, H. (2020) · Neuroreport · doi:10.1097/wnr.0000000000001399 · Cited by 8
Metadata
- Authors
- Evans, S. J., Choudary, P. V., Neal, C. R., Li, J. Z., Vawter, M. P., Tomita, H., Lopez, J. F., Thompson, R. C., Meng, F., Stead, J. D., Walsh, D. M., Myers, R. M., Bunney, W. E., Watson, S. J., Jones, E. G., & Akil, H.
- Affiliations
- University of California, Irvine (US)
- Department of Psychiatry and Mental Health Research Institute, University of Michigan, Ann Arbor, MI 48109; Human Genome Center, Stanford University, Palo Alto, CA 94304; Center for Neuroscience, University of California, Davis, CA 95616; and Department of Psychiatry and Human Behavior, University of California, Irvine, CA 92697
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-10-13
- Volume
- 101
- Issue
- 43
- Pages
- 15506-15511
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC523463
- OpenAlex
- W2150092716
- Cited by
- 424
- References
- 38
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 20 · 2023: 15 · 2022: 19 · 2021: 21 · 2020: 10 · 2019: 22 · 2018: 20 · 2017: 26 · 2016: 15 · 2015: 23 · 2014: 15 · 2013: 20 · 2012: 20
- FWCI
- 12.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Michigan
- National Institutes of Health
- University of California, Davis
- University of California, Irvine
- National Institute of Mental Health (P50MH060398, #L99MH60398)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- major depressive disorder, gene expression dysregulation, frontal cortex, bipolar disorder, serotonin reuptake inhibitors, antidepressant mechanism, growth factor receptors, postmortem brain
- MeSH terms
- Adult, Aged, Aged, 80 and over, Major Depressive Disorder, Female, Fibroblast Growth Factors, Humans, Male, Middle Aged, Polymerase Chain Reaction, Selective Serotonin Reuptake Inhibitors, In Situ Hybridization, Oligonucleotide Array Sequence Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.